Literature DB >> 26985678

Strong inflammatory response and Th1-polarization profile in children with acute lymphoblastic leukemia without apparent infection.

E Pérez-Figueroa1, M Sánchez-Cuaxospa1, K A Martínez-Soto1, N Sánchez-Zauco1, A Medina-Sansón2, E Jiménez-Hernández3, J R Torres-Nava3, J M Félix-Castro4, A Gómez5, E Ortega6, C Maldonado-Bernal1.   

Abstract

Children with acute lymphoblastic leukemia (ALL) often present fever. Febrile states are usually associated with infectious processes that generate an inflammatory response involving various molecules, including cytokines. However, an inflammatory response may also occur in the absence of infection. We hypothesized that the levels of inflammatory cytokines are increased in children with ALL without apparent infection. The serum levels of 13 cytokines in 99 patients with ALL and 48 non-oncological patients without apparent infection were measured using multiplex analyte profiling technology (Luminex®). The concentration of circulating pro-inflammatory cytokines associated with fever was similar between patients with ALL and fever at diagnosis and those without fever. The levels of tumor necrosis factor α, interleukin (IL)-6, IL-8, monocyte chemoattractant protein-1 (MCP-1) and IL-10 were higher in patients with ALL vs. the control group (P<0.05). Moreover, the levels of the T helper 1 (interferon‑γ and IL-12) cytokines were higher in patients with ALL vs. the control group. Transforming growth factor β was lower in patients with ALL vs. the control group (P<0.05). The levels of IL-1β, IL-2, IL-4, IL-13, and IL-17 were similar in the two groups. Our results indicate that the circulating levels of seven of the important studied cytokines are elevated in patients with newly diagnosed ALL without apparent infection, reflecting a strong and deregulated inflammatory state in this disease, with a Th1-polarization profile.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26985678     DOI: 10.3892/or.2016.4657

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

Review 1.  The Bone Marrow Microenvironment in B-Cell Development and Malignancy.

Authors:  Anastasia M Hughes; Vincent Kuek; Rishi S Kotecha; Laurence C Cheung
Journal:  Cancers (Basel)       Date:  2022-04-22       Impact factor: 6.575

2.  Induction chemotherapy reduces extracellular heat shock protein 72 levels, inflammation, lipoperoxidation and changes insulin sensitivity in children and adolescents newly diagnosed with acute lymphoblastic leukemia.

Authors:  Ana Paula Trussardi Fayh; Camila de Carvalho Gomes; Helena Trevisan Schroeder; Carlos Henrique de Lemos Muller; Telma Maria de Araújo Moura Lemos; Mauricio Krause
Journal:  Oncotarget       Date:  2018-06-19

Review 3.  The NLRP3 Inflammasome and Its Role in the Pathogenicity of Leukemia.

Authors:  Laura Urwanisch; Michela Luciano; Jutta Horejs-Hoeck
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923

4.  Prognostic Relevance of Expression of EMP1, CASP1, and NLRP3 Genes in Pediatric B-Lineage Acute Lymphoblastic Leukemia.

Authors:  Jay Singh; Sarita Kumari; Mohit Arora; Deepak Verma; Jayanth Kumar Palanichamy; Rajive Kumar; Gunjan Sharma; Sameer Bakhshi; Deepam Pushpam; M Shadab Ali; Amar Ranjan; Pranay Tanwar; Shyam S Chauhan; Archna Singh; Anita Chopra
Journal:  Front Oncol       Date:  2021-03-05       Impact factor: 5.738

5.  Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemia.

Authors:  Takashi Mikami; Itaru Kato; James Badger Wing; Hiroo Ueno; Keiji Tasaka; Kuniaki Tanaka; Hirohito Kubota; Satoshi Saida; Katsutsugu Umeda; Hidefumi Hiramatsu; Tomoya Isobe; Mitsuteru Hiwatari; Ai Okada; Kenichi Chiba; Yuichi Shiraishi; Hiroko Tanaka; Satoru Miyano; Yuki Arakawa; Koichi Oshima; Katsuyoshi Koh; Souichi Adachi; Keiko Iwaisako; Seishi Ogawa; Shimon Sakaguchi; Junko Takita
Journal:  Cancer Sci       Date:  2021-11-29       Impact factor: 6.716

6.  P38 MAPK/AKT signalling is involved in IL-33-mediated anti-apoptosis in childhood acute lymphoblastic leukaemia blast cells.

Authors:  Yiqian Wang; Hanyi Hou; Zhongping Liang; Xuexin Chen; Xindan Lian; Jie Yang; Zeyu Zhu; Huanmin Luo; Haibo Su; Qing Gong
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 7.  Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia.

Authors:  Silvia Jiménez-Morales; Ivan Sammir Aranda-Uribe; Carlos Jhovani Pérez-Amado; Julian Ramírez-Bello; Alfredo Hidalgo-Miranda
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561

8.  Atopy manifestations in pediatric patients with acute lymphoblastic leukemia: correlation assessment with interleukin-4 (IL-4) and IgE level.

Authors:  Omid Reza Zekavat; Elham Nikpendar; Sezaneh Haghpanah; Negin Shokrgozar; Seyed Javad Dehghani; Nargess Arandi
Journal:  BMC Pediatr       Date:  2022-03-21       Impact factor: 2.125

9.  Acute lymphoblastic leukemia cells are able to infiltrate the brain subventricular zone stem cell niche and impair neurogenesis.

Authors:  Lidia M Fernández-Sevilla; Germán Belenguer; Beatriz Martí-Prado; Paula Ortiz-Sánchez; Manuel Ramírez; Alberto Varas; Isabel Fariñas; Ángeles Vicente
Journal:  Haematologica       Date:  2022-04-01       Impact factor: 9.941

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.